In a first-of-its-kind study, researchers at 23andMe found a link between the susceptibility for some of the most common infectious diseases and dozens of specific variants in genes involved in the body’s frontline immune response system.
A new survey found that most Americans are interested in using DNA testing to understand more about their health and ancestry, but the national survey also revealed a need for better education around the science of genetics.
For the first time, researchers have identified genetic variants that put some women at a higher risk of having a premature baby — findings that may ultimately help scientists prevent what is the leading cause of childhood mortality worldwide.
Last week, 23andMe released two new genetic health risk reports for customers.
23andMe recently started offering customers new Genetic Health Risk reports that have received FDA authorization. Below we’ve highlighted some important features in these reports to help you get more out of them.
The U.S. Food and Drug Administration granted 23andMe authorization to offer 10 genetic health risk reports including late-onset Alzheimer’s disease, Parkinson’s disease, celiac disease and a condition associated with harmful blood clots.
A new Fertility Research Community launched by the next-generation women’s health company Celmatix, and 23andMe, will use genetic and other data to uncover more on what impacts a woman’s ability to conceive.
When did that 2 percent Yakut ancestry make its way into your family tree? The newest 23andMe Ancestry feature may have the answer for you.
Some websites and products have made bold claims that common genetic variants in MTHFR can cause a wide array of health conditions. So we decided to dig deeper into the published scientific literature to evaluate the evidence.
As part of a collaboration with 23andMe, the personalized medicine company Celmatix is looking to dramatically improve the diagnosis and treatment of infertility.
